Clinical research is a notoriously cost-sensitive industry. The Tufts Center for the Study of Drug Development estimated the average cost of bringing a new drug to market to be over $2 billion – and with clinical trial costs on the rise, it’s more important than ever to take a smart approach to developing your study budgets. This is especially true when taking on global clinical trials.

On Monday, December 10, join Medrio and Débora S. Araujo, founder and CEO of the pharmaceutical skill development company ClinBiz, for a brand-new webinar: How to Develop a Global Clinical Study Budget Like a Pro. The webinar will offer organizations conducting clinical trials insight into a host of critical issues related to various aspects of clinical study budgets, and will be a key resource for any organization looking to increase the cost-efficiency of their clinical trials.

Key takeaways:

What questions to ask yourself during the clinical study budget development stage to avoid pushback from senior management at the budget approval stage
What to include in your clinical study budget package so your budget gets approval quickly
How to use benchmarks to achieve bulletproof clinical study budget estimates

In the current environment, organizations must do whatever possible to mitigate the costs of bringing new products to market approval. What approach will you take to budget planning in your next study?

Keywords:

Speaker

Débora S. Araujo, Founder & CEO, ClinBiz

Débora S. Araujo has over a decade of experience in the pharmaceutical industry working and consulting for Fortune 500 companies. Her focus is on the business aspects of clinical trials, including clinical contracting and financial management, clinical outsourcing and CRO/vendor management, global clinical trial budgeting and forecasting, clinical financial analytics and metrics/KPIs, site budget development and negotiations, fair market value and global investigator site payments. She has utilized her expertise to drive change in the industry via thought leadership material, conference presentations and consulting engagements. Débora’s passion for driving practical change in the industry led her to launch ClinBiz, an online platform where clinical research professionals can stay connected and updated on the latest topics, trends and technologies related to the business aspects of clinical trials. Débora is also the author of the bestselling book, “The Four Villains of Clinical Trial Agreement Delays and How To Defeat Them.”

Message Presenter

Who Should Attend?

Senior clinical trial and clinical data managers, and clinical operations professionals, including project leads from pharmaceutical, biotechnology, medical device, and diagnostics companies.

What You Will Learn

What questions to ask yourself during the clinical study budget development stage to avoid push back from senior management at the budget approval stage
What to include in your clinical study budget package so your budget gets approval quickly
How to use benchmarks to achieve bulletproof clinical study budget estimates

Xtalks Partners

ClinBiz

Many professionals dealing with the business aspects of clinical trials are unable to attend traditional industry conferences on an ongoing basis to develop their skills and continue to grow in their field. ClinBiz hopes to bridge this gap by providing a non-traditional format including a YouTube channel, blog, podcast, an online annual event and more that will serve as a connection and development tool that clinical business professionals can use to remain on top of the latest trends, topics and technologies related to their trade from virtually anywhere.

Medrio

Medrio is a leading healthcare technology company providing eClinical solutions including EDC, eSource, and ePRO for clinical research. Founded in 2005, the company’s cloud-based software platform and mobile suite of products deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively across drug, device, diagnostic, and animal health trials. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit www.medrio.com.